(Q47182880)

11 January 2018

title

C-reactive protein and coronary artery disease: influence of obesity, caloric restriction and weight loss (English)

1 reference

11 January 2018

main subject

obesity

0 references

coronary artery disease

1 reference

1 reference

2

1 reference

11 January 2018

author name string

Leonie K. Heilbronn

series ordinal

1

1 reference

11 January 2018

publication date

1 June 2002

1 reference

11 January 2018

Journal of Nutritional Biochemistry

published in

1 reference

11 January 2018

volume

13

1 reference

11 January 2018

issue

6

1 reference

11 January 2018

page(s)

316-321

1 reference

11 January 2018

The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2802%2900187-0

7 January 2021

Interleukin-6-dependent and -independent regulation of the human C-reactive protein gene

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2802%2900187-0

7 January 2021

Atherosclerosis — An Inflammatory Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2802%2900187-0

7 January 2021

Elevation of C-reactive protein in "active" coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2802%2900187-0

7 January 2021

The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2802%2900187-0

7 January 2021

Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2802%2900187-0

7 January 2021

Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2802%2900187-0

7 January 2021

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2802%2900187-0

7 January 2021

C-reactive protein and coronary heart disease in western Turkey

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2802%2900187-0

7 January 2021

Association of C-reactive protein with markers of prevalent atherosclerotic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2802%2900187-0

7 January 2021

C-reactive protein is not associated with the presence or extent of calcified subclinical atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2802%2900187-0

7 January 2021

Interleukin 6 gene transcripts are expressed in human atherosclerotic lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2802%2900187-0

7 January 2021

Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2802%2900187-0

7 January 2021

Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2802%2900187-0

7 January 2021

Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2802%2900187-0

7 January 2021

Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2802%2900187-0

7 January 2021

Simvastatin has anti-inflammatory and antiatherosclerotic activities independent of plasma cholesterol lowering

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2802%2900187-0

7 January 2021

Antiinflammatory and antiarteriosclerotic actions of HMG-CoA reductase inhibitors in a rat model of chronic inhibition of nitric oxide synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2802%2900187-0

7 January 2021

Immunohistochemical localization of the terminal C5b-9 complement complex in human aortic fibrous plaque

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2802%2900187-0

7 January 2021

C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2802%2900187-0

7 January 2021

Complement and atherogenesis: binding of CRP to degraded, nonoxidized LDL enhances complement activation

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2802%2900187-0

7 January 2021

Atherogenic properties of enzymatically degraded LDL: selective induction of MCP-1 and cytotoxic effects on human macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2802%2900187-0

7 January 2021

Direct proinflammatory effect of C-reactive protein on human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2802%2900187-0

7 January 2021

Interferon-gamma and lipopolysaccharide potentiate monocyte tissue factor induction by C-reactive protein: relationship with age, sex, and hormone replacement treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2802%2900187-0

7 January 2021

C-reactive protein in population samples

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2802%2900187-0

7 January 2021

Chronic infections and coronary heart disease: is there a link?

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2802%2900187-0

7 January 2021

Elevated C-reactive protein levels in overweight and obese adults

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2802%2900187-0

7 January 2021

C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2802%2900187-0

7 January 2021

Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project.

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2802%2900187-0

7 January 2021

C-reactive protein concentration in children: relationship to adiposity and other cardiovascular risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2802%2900187-0

7 January 2021

Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2802%2900187-0

7 January 2021

Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2802%2900187-0

7 January 2021

C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2802%2900187-0

7 January 2021

Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2802%2900187-0

7 January 2021

Relation of C-reactive protein to body fat distribution and features of the metabolic syndrome in Europeans and South Asians

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2802%2900187-0

7 January 2021

C-reactive protein levels as a direct indicator of interleukin-6 levels in humans in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2802%2900187-0

7 January 2021

Interleukin-6 exacerbates early atherosclerosis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2802%2900187-0

7 January 2021

Angiotensin II administration to atherosclerotic mice increases macrophage uptake of oxidized ldl: a possible role for interleukin-6.

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2802%2900187-0

7 January 2021

Complement-dependent acute-phase expression of C-reactive protein and serum amyloid P-component

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2802%2900187-0

7 January 2021

Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2802%2900187-0

7 January 2021

Insulin resistance and inflammation in an evolutionary perspective: the contribution of cytokine genotype/phenotype to thriftiness

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2802%2900187-0

7 January 2021

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2802%2900187-0

7 January 2021

The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2802%2900187-0

7 January 2021

Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2802%2900187-0

7 January 2021

Body mass index, diabetes, and C-reactive protein among U.S. adults

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2802%2900187-0

7 January 2021

Hormone replacement therapy and increased plasma concentration of C-reactive protein

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2802%2900187-0

7 January 2021

Serum levels of C-reactive protein are associated with obesity, weight gain, and hormone replacement therapy in healthy postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2802%2900187-0

7 January 2021

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2802%2900187-0

7 January 2021

Weight loss and progression of early atherosclerosis in the carotid artery: a four-year controlled study of obese subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2802%2900187-0

7 January 2021

Energy restriction and weight loss on very-low-fat diets reduce C-reactive protein concentrations in obese, healthy women

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2802%2900187-0

7 January 2021

Weight loss reduces C-reactive protein levels in obese postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2802%2900187-0

7 January 2021

Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2802%2900187-0

7 January 2021

Tumor Necrosis Factor-α Induces Interleukin-6 Production and Integrin Ligand Expression by Distinct Transduction Pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2802%2900187-0

7 January 2021

Calorie restriction attenuates inflammatory responses to myocardial ischemia-reperfusion injury

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2802%2900187-0

7 January 2021

Attenuated allergic responses to house dust mite antigen in feed-restricted rats

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2802%2900187-0

7 January 2021

Caloric restriction as a mechanism mediating resistance to environmental disease

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2802%2900187-0

7 January 2021

Troglitazone prevents the inhibitory effects of inflammatory cytokines on insulin-induced adipocyte differentiation in 3T3-L1 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2802%2900187-0

7 January 2021

Characterization of differentiation factor/leukaemia inhibitory factor effect on lipoprotein lipase activity and mRNA in 3T3-L1 adipocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2802%2900187-0

7 January 2021

C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2802%2900187-0

7 January 2021

10.1016/S0955-2863(02)00187-0

Identifiers

DOI

1 reference

11 January 2018

PubMed ID

12088796

1 reference

11 January 2018